IP Library › Granted Patent US 10,838,236
Granted Patent B2
US 10,838,236 · App. 16/421,843 · Granted Nov 17, 2020

High plus treatment zone lens design and method for preventing and/or slowing myopia progression

Inventors: Noel A. Brennan (Jacksonville, FL); Khaled Chehab (Jacksonville, FL); Xu Cheng (St. Johns, FL); Michael J. Collins (Jollys Lookout, AU); Manwai Charis Lau (Jacksonville, FL); Eric R. Ritchey (St. Johns, FL); Xin Wei (Jacksonville, FL)
Assignee: Johnson & Johnson Vision Care, Inc
G02C7/066A61F2/142A61F2/145A61F2/16A61F2/1618G02C7/04G02C7/041G02C7/044G02C7/048G02C7/06G02C2202/24
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,838,236
App. No.
16/421,843
Granted
Nov 17, 2020
Kind
B2
Abstract

Contact lenses incorporate high plus or add power profiles that at least one of slow, retard or preventing myopia progression and minimize halo effect. The lens includes a center zone with a negative power for myopic vision correction; and at least one treatment zone surrounding the center zone, the at least one treatment zone having a power profile that increases from an outer margin of the center zone to a positive power within the at least one treatment zone of greater than +5.00 D.

Claims (8)

1. An ophthalmic lens for at least one of slowing, retarding or preventing myopia progression in a patient, the ophthalmic lens comprising:

a treatment zone with a negative dioptric power adapted to correct myopic vision of said patient; and

at least one enhanced treatment zone having an ADD power relative to said negative dioptric power of said treatment zone, wherein said ADD power is between +5 D and +15 D,

wherein the at least one enhanced treatment zone is positioned at a center of said ophthalmic lens and extends to a radius of about 0.7 mm from said center.

2. The ophthalmic lens according to claim 1 , wherein the ADD power within said enhanced treatment zone is between +10 D and +15 D.

3. The ophthalmic lens according to claim 1 , wherein the ADD power within said enhanced treatment zone is a stepped increase in add power.

4. The ophthalmic lens according to claim 1 , further comprising a second enhanced treatment zone having an ADD power relative to said negative dioptric power of said treatment zone.

5. The ophthalmic lens according to claim 1 , wherein said enhanced treatment zone has a radius of 0.75 mm.

Continuity (3)
Continuation 15461869 · Mar 17, 2017
Division 14464182 · Aug 20, 2014
Related Publication 20190278106A1 · Sep 12, 2019
Cited By (2)
US 12,239,529 US 12,736,832